APA (7th ed.) Citation

K, W., CA, T., P, d. G., MA, P., AG, P., M, C., . . . B, Z. (2025). First Report of Response to Tarlatamab in a Patient With Histologic-Transformed SCLC From ALK-Rearranged NSCLC: Case Report. JTO clinical and research reports, 7(2), 100941. https://doi.org/10.1016/j.jtocrr.2025.100941

Chicago Style (17th ed.) Citation

K, Wang, et al. "First Report of Response to Tarlatamab in a Patient With Histologic-Transformed SCLC From ALK-Rearranged NSCLC: Case Report." JTO Clinical and Research Reports 7, no. 2 (2025): 100941. https://doi.org/10.1016/j.jtocrr.2025.100941.

MLA (9th ed.) Citation

K, Wang, et al. "First Report of Response to Tarlatamab in a Patient With Histologic-Transformed SCLC From ALK-Rearranged NSCLC: Case Report." JTO Clinical and Research Reports, vol. 7, no. 2, 2025, p. 100941, https://doi.org/10.1016/j.jtocrr.2025.100941.